Cerus (CERS) EBIT Margin Growth (3y) (2013 - 2026)
Cerus (CERS) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -184.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,505.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -3,846.00 |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 10,018.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,018.00 |
| Dec 31, 2025 | -1,380.00 |
| Sep 30, 2025 | 198,271.00 |
| Jun 30, 2025 | 133.00 |
| Mar 31, 2025 | 5,300.00 |
| Dec 31, 2024 | 407.00 |
| Sep 30, 2024 | 363,386.00 |
| Jun 30, 2024 | 234,845.00 |
| Mar 31, 2024 | 359,639.00 |
| Dec 31, 2023 | -3,321.00 |
| Sep 30, 2023 | 23,721.00 |
| Jun 30, 2023 | -110,640.00 |
| Mar 31, 2023 | 2,520.00 |
| Dec 31, 2022 | -15,360.00 |
| Sep 30, 2022 | -188,122.00 |
| Jun 30, 2022 | 4,634.00 |
| Mar 31, 2022 | 6,046.00 |
| Dec 31, 2021 | 8,745.00 |
| Sep 30, 2021 | -354,760.00 |
| Jun 30, 2021 | -206,578.00 |